WitrynaGastrointestinal stromal tumors (GISTs) are rare, mesenchymal tumors of the gastrointestinal tract, characterized by either KIT or PDGFRA mutation in about 85% of cases. KIT/PDGFRA wild type gastrointestinal stromal tumors (wtGIST) account for the remaining 15% of GIST and represent an unmet medical need: their prevalence and … Witryna14 lip 2024 · Gastrointestinal stromal tumors (GIST) are the most common mesenchymal soft tissue sarcoma of the gastrointestinal tract. The management of locally advanced …
ExpertPerspectives
Witryna15 cze 2024 · Learning to Beat the Clock—Stressing the Timing of Immunotherapy. Jun 15, 2024. Andrew Smith. Targeted Therapies in Oncology June 1, 2024. Volume 11. Issue 8. Pages: 24. Most studies of how timing affects immunotherapy efficacy have defined “timing” relative to other treatments, but some research has investigated the … Witryna2 dni temu · THIO (6-thio-2’-deoxyguanosine) plus cemiplimab (Libtayo) administered in a sequential combination did generate any dose-limiting toxicities (DLTs) or significant treatment-related adverse events (AEs) among patients with advanced non–small cell lung cancer (NSCLC), according to topline data from the safety lead-in portion, part A, … irish tweed hats for babies
Recurrence-Free Survival in GIST at 90% With Long-Term Imatinib
WitrynaThe purpose of this study is to assess the safety, effectiveness, and pharmacokinetics of THE-630 in participants with advanced gastrointestinal stromal tumors (GIST). … Witryna25 sie 2024 · Patients received 1500 mg of durvalumab every 4 weeks plus 75 mg of tremelimumab every 4 weeks for 4 cycles followed by durvalumab alone every 4 weeks for up to 12 months or until intolerable toxicity or disease progression. Results showed that durvalumab/tremelimumab elicited a response rate of 14.3%. In the liposarcoma … WitrynaImmunotherapy and targeted therapy. Targeted therapies use certain drugs to target and attack proteins in GISTs that allow them to grow and multiply. For example, … irish tweed hats for kids